19434-42-5

Basic information

• Product Name: 5-Amino-(1,1'-biphenyl)-2-ol
• Synonyms: 5-Amino-(1,1'-biphenyl)-2-ol;4-AMINO-2-PHENYLPHENOL
• CAS NO: 19434-42-5
• Molecular Formula: C₁₂H₁₁NO
• Molecular Weight: 185.22544
• Mol File: 19434-42-5.mol
• Article Data: 13

Chemical Properties

• Melting Point: 201 °C
• Boiling Point: 384.7 °C at 760 mmHg
• Flash Point: 186.4 °C
• Appearance: /
• Density: 1.191 g/cm³
• PKA: 10.25±0.18(Predicted)
• CAS DataBase Reference: 5-Amino-(1,1'-biphenyl)-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Amino-(1,1'-biphenyl)-2-ol(19434-42-5)
• EPA Substance Registry System: 5-Amino-(1,1'-biphenyl)-2-ol(19434-42-5)

Safety Data

• Hazardous Substances Data: 19434-42-5(Hazardous Substances Data)

Usage

Uses

4-Amino-2-phenylphenol is phenylphenol derivative with herbicidal and fungicidal activity.

Upstream product

• 947607-09-2 2-benzyloxy-5-nitro-biphenyl 
• 56970-26-4 6-methoxy-[1,1’-biphenyl]-3-amine 
• 90-43-7 2-Phenylphenol 
• 79380-82-8 2-phenyl-4-phenylazophenol 
• 139-59-3 4-phenoxyanilin 
• 36697-36-6 2-chlorophenyl-2,5-cyclohexadiene-1,4-dione 4-oxime 
• 305-80-6 4-diazobenzenesulfonic acid 
• 38104-96-0 5-Nitroso-biphenyl-2-ol 
• 4291-29-6 5-nitrobiphenyl-2-ol 

Downstream Products

• 530084-81-2 6-ethoxy-biphenyl-3-ylamine 
• 55382-49-5 5-chloro-2-methoxy-1,1'-biphenyl 
• 86177-20-0 N-(4-Chloro-phenyl)-N'-[4-(5-diethylaminomethyl-6-hydroxy-biphenyl-3-ylamino)-6-trifluoromethyl-pyrimidin-2-yl]-guanidine 
• 101712-68-9 3-(tert-Butylamino-methyl)-5-(7-chloro-1-oxy-quinolin-4-ylamino)-biphenyl-2-ol 
• 101712-66-7 5-(7-Chloro-1-oxy-quinolin-4-ylamino)-3-diethylaminomethyl-biphenyl-2-ol 
• 101712-67-8 3-(tert-Butylamino-methyl)-5-(7-chloro-quinolin-4-ylamino)-biphenyl-2-ol 
• 101712-65-6 5-(7-chloro-[4]quinolylamino)-3-diethylaminomethyl-biphenyl-2-ol 
• 66723-72-6 N-Benzoyl-2-hydroxy-5-aminobiphenyl 
• 607-12-5 5-chloro-biphenyl-2-ol 
• 29785-41-9 N-<6-hydroxy<1,1'-biphenyl>-3-yl>acetamide 

Relevant articles and documents

DERIVATIVES OF 6-SUBSTITUTED TRIAZOLOPYRIDAZINES AS REV-ERB AGONISTS

The present invention provides novel 6-substituted [1,2,4]triazolo[4,3-b]pyridazines that are agonists of Rev-Erb. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the activation of Rev-Erb has therapeutic effects, for instance in inflammatory and circadian rhythm-related disorders or cardiometabolic diseases.

PYRROLIDINE DERIVATIVES AS ERK INHIBITORS

Disclosed are the ERK inhibitors of Formula (1.0): and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of Formula (1.0).

Aryl aniline beta2 adrenergic receptor agonists

The invention provides novel β2 adrenergic receptor agonist compounds of formula (I): wherein R1-R13 and w have any of the values described in the specification. The invention also provides combinations of such compounds and other therapeutic agents, pharmaceutical compositions comprising such compounds and combinations, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.